日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

New perspectives in the treatment of liver cirrhosis: targeting macrophage regulatory mechanisms

肝硬化治疗的新视角：靶向巨噬细胞调控机制

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-025-07239-y
Zheng, Shihao; Li, Size; Wang, Qiuyue; Zao, Xiaobin; Li, Xiaoke; Qi, Wenying; Cheng, Fane; Geng, Yuexiao; Zhang, Peng; Shi, Xinyue; Ye, Yongan
巨噬细胞
巨噬细胞
信号转导
肝硬化
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Mechanistic insights into traditional Chinese medicine for viral pneumonia treatment: signaling pathway perspectives

从信号通路角度探讨中医药治疗病毒性肺炎的机制

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1577580
Zheng, Shihao; Xue, Tianyu; Li, Size; Qi, Wenying; Zao, Xiaobin; Zhang, Peng; Cheng, Fan-E; Ye, Yongan; Dong, Peipei
肺炎
信号转导
毒理研究
微生物学
发表日期：2025
文献求助 收藏

Exploring the mechanism of action of Jinqiancao granules against liver cirrhosis based on the liver-gut axis

基于肝肠轴探讨金千草颗粒治疗肝硬化的作用机制

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1686535
Cheng, Fan-E; Zhang, Yaxi; Zheng, Shihao; Qi, Wenying; Zhang, Xiaomei; Li, Size; Wang, Qiuyue; Zou, Xiangyun; Li, Xiaoke; Ye, Yongan; Zao, Xiaobin
肝硬化
发表日期：2025
文献求助 收藏

A Comprehensive Study Employing Computational Analysis and Mendelian Randomization Has Revealed the Impact of Key Genes on Liver Cancer.

一项采用计算分析和孟德尔随机化的综合研究揭示了关键基因对肝癌的影响

期刊:Biomedicines
影响因子:3.9
doi:10.3390/biomedicines13061313
Li Size, Qi Wenying, Wu Junzheng, Luo Chunhua, Zheng Shihao, Cao Xu, Wang Wei, Liu Qiyao, Du Hongbo, Li Xiaoke, Zao Xiaobin, Ye Yongan
肿瘤
肝癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Downregulation of UDP-glucose 6-dehydrogenase predicts adverse outcomes in patients with colorectal cancer and promotes tumorigenesis.

UDP-葡萄糖6-脱氢酶的下调预示着结直肠癌患者的不良预后，并促进肿瘤发生

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-07889-4
Wang Mengyuan, Ge Zhiming, Fan Xianxian, Zhao Hongbo, Shi Zhenfu, Zhang Jiucun, Jin Li, Li Yan, Wang Jie, Zao Xiaobin, Yang Yun
肿瘤
肠癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Traditional Chinese Medicine for Liver Cancer Treatment: Network Pharmacology Research

传统中药治疗肝癌：网络药理学研究

期刊:Current Topics in Medicinal Chemistry
影响因子:3.3
doi:10.2174/0115680266336478241118065659
Zheng, Shihao; Gu, Yixiao; Qi, Wenying; Wang, Wei; Li, Xiaoke; Zao, Xiaobin; Li, Size; Liu, Shaoyu; Xue, Tianyu; Ye, Yongan; Liu, Aimin
肿瘤
肝癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Liver cirrhosis: current status and treatment options using western or traditional Chinese medicine

肝硬化：现状及西医或中医治疗方案

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2024.1381476
Zheng, Shihao; Xue, Chengyuan; Li, Size; Zao, Xiaobin; Li, Xiaoke; Liu, Qiyao; Cao, Xu; Wang, Wei; Qi, Wenying; Du, Hongbo; Zhang, Peng; Ye, Yongan
肝硬化
发表日期：2024
文献求助 收藏

Chinese medicine in the treatment of non-alcoholic fatty liver disease based on network pharmacology: a review

基于网络药理学的中医药治疗非酒精性脂肪肝：综述

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2024.1381712
Zheng, Shihao; Xue, Chengyuan; Li, Size; Zao, Xiaobin; Li, Xiaoke; Liu, Qiyao; Cao, Xu; Wang, Wei; Qi, Wenying; Zhang, Peng; Ye, Yongan
脂肪肝
代谢
发表日期：2024
文献求助 收藏

Application of network pharmacology in traditional Chinese medicine for the treatment of digestive system diseases

网络药理学在中医治疗消化系统疾病中的应用

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2024.1412997
Zheng, Shihao; Liang, Yijun; Xue, Tianyu; Wang, Wei; Li, Size; Zhang, Peng; Li, Xiaoke; Cao, Xu; Liu, Qiyao; Qi, Wenying; Ye, Yongan; Zao, Xiaobin
发表日期：2024
文献求助 收藏

Chinese medicine in the treatment of chronic hepatitis B: The mechanisms of signal pathway regulation

中医药治疗慢性乙型肝炎：信号通路调控机制

期刊:Heliyon
影响因子:3.6
doi:10.1016/j.heliyon.2024.e39176
Zheng, Shihao; Qi, Wenying; Xue, Tianyu; Zao, Xiaobin; Xie, Jinchi; Zhang, Peng; Li, Xiaoke; Ye, Yongan; Liu, Aimin
信号转导
肝炎
发表日期：2024
文献求助 收藏